• linkedin
  • Increase Font
  • Sharebar

    Study: No significant link between diabetes Tx, bladder Ca

    A new study reports no statistically significant increase in the risk of bladder cancer among patients treated with the diabetes drug pioglitazone (Actos), despite previous studies suggesting an association. 

    However, the authors, led by Assiamira Ferrara, MD, PhD, of Kaiser Permanente Northern California, Oakland, did find a possible link between pioglitazone and prostate and pancreatic cancer. They reported their findings in JAMA (2015; 314:265-77).

    Related - Best of AUA 2015: Bladder Cancer

    To explore the relationship between pioglitazone and bladder cancer, the investigators performed a cohort analysis of 193,099 diabetic patients and a nested case-control analysis of 464 bladder cancer patients and 464 matched controls. The patients, who were all 40 years of age or older in 1997 through 2002 and from Kaiser Permanente Northern California, were followed until December 2012.

    A second cohort analysis of 236,507 patients, also from Kaiser Permanente and 40 years of age or older in 1997 through 2005, considered pioglitazone in relation to 10 additional cancers (prostate, female breast, lung/bronchus, endometrial, colon, non-Hodgkin lymphoma, pancreas, kidney/renal pelvis, rectum, and melanoma). It followed the patients until June 2012.

    NEXT: No significant association between pioglitazone, bladder cancer

    Want more Urology Times?

    Long-term benefits observed with sling procedures

    Low-risk PCa: Higher radiation dose shows no benefit

    Blog: Practice ‘efficiency’ is not a dirty word but a noble goal

    3 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • Dr. kalyanaraman
      I completely trust the study which was supported by a grant from........THE MANUFACTURER of the drug!! Absolutely no conflict of interest there. Urology Times should do a better job of informing the readers of such critical information.
    • MarciaHiggins
      Gotta love when people focus on spreading awareness and information about Diabetes. I was diagnosed with Type 2 one year ago, and spent the first few months relying on Metformin and doctor instructions to try and deal with it. If only I had known back then how effective natural treatments, like those in the Diabetes Destroyer (http://steamspoils.com/diabetes-destroyer-review/ ) are. After seeing no results with Metformin and still having a blood glucose level of 140, I turned to natural methods like diet/exercise to try and get my life together. That book was big a help. Now, months later, I've dropped 30 pounds and have a fasted blood sugar level of 70-80.
    • Dr. kalyanaraman
      Who's this troll? What's next - an endorsement of male enhancement pills??

    Poll